TrialCNS drugs2019

Long-Term Neuropsychological Outcomes from an Open-Label Phase I/IIa Trial of 2-Hydroxypropyl-β-Cyclodextrins (VTS-270) in Niemann-Pick Disease, Type C1.

Cristan A Farmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.